Log in

Amrutanjan Health Care

NSE: AMRUTANJAN · ISIN INE098F01031 · Healthcare

₹515.00−2.80 (−0.54%)

Monday 9 November, 12:04 IST. Delayed. Source: Yahoo Finance.

Price chart

₹515.00 −2.80 (−0.54%) today

The day

Previous close
₹517.80
Open
₹513.10
Day high
₹520.50
Day low
₹499.80

Listed on NSE since 2 January 2015.

Key numbers

Market value
₹1,486.76 Cr
P/E (trailing)
27.55
EPS (trailing)
₹18.67
Price to book
4.02
Dividend yield
0.98%
Debt to equity
0.00
Profit margin
10.6%
Beta
0.42
Volume today
39,800
Average volume
82,938

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹378.23 Cr₹39.83 Cr₹13.63
FY24₹420.12 Cr₹44.97 Cr₹15.50
FY25₹450.51 Cr₹50.83 Cr₹17.58
FY26₹501.68 Cr₹57.92 Cr₹20.03

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹135 Cr₹17 Cr₹5.98+23.8%
Q1 FY27Apr–Jun 2026₹103 Cr₹4 Cr₹1.51−47.5%
Q4 FY26Jan–Mar 2026Audited₹150 Cr₹16 Cr₹5.60+6.7%
Q3 FY26Oct–Dec 2025₹141 Cr₹19 Cr₹6.73–
Q2 FY26Jul–Sep 2025₹118 Cr₹14 Cr₹4.83–
Q1 FY26Apr–Jun 2025₹94 Cr₹8 Cr₹2.87–

Source: Amrutanjan Health Care’s results filed with NSE, standalone (the company alone). Net profit is the share of Amrutanjan Health Care’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹189 Cr₹155 Cr₹74 Cr
Investments₹3 Cr₹3 Cr₹0
Inventories₹58 Cr₹37 Cr₹36 Cr
Owed by customers₹44 Cr₹61 Cr₹38 Cr
Cash and equivalents₹8 Cr₹11 Cr₹5 Cr
Total assets₹515 Cr₹509 Cr₹432 Cr
Borrowings₹0₹0₹0
Total liabilities₹131 Cr₹139 Cr₹90 Cr
Shareholders’ equity₹384 Cr₹370 Cr₹342 Cr

Source: Amrutanjan Health Care’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

About Amrutanjan Health Care

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene & Personal Care, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and enerlyte and electro, and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Chennai
Employees
661

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Amrutanjan Health Care in the last day or two.

Dividends and corporate actions

All companies
  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 6 November 2026 · record date 7 November 2026

  • Dividend - Rs 2.90 Per Share

    Dividend · ex-date 11 September 2026

  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 6 February 2026 · record date 7 February 2026

  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 18 November 2025

  • Dividend - Rs 2.60 Per Share

    Dividend · ex-date 16 September 2025

  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 18 February 2025

  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 22 November 2024

  • Annual General Meeting

    Action · ex-date 13 September 2024

Source: NSE. Latest first, 8 of 20.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.